Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Vsa polja
Naslov
Avtor
Tema
Signatura
ISBN/ISSN
Oznaka
Išči
Napredno
Treatment reduction for childr...
Citiraj
Pošljite SMS
Pošljite email
Natisni
Izvozi zadetek
Izvozi v RefWorks
Izvozi v EndNoteWeb
Izvozi v EndNote
Permanent link
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
Show other versions (1)
Bibliografske podrobnosti
Main Authors:
Vora, A
,
Goulden, N
,
Wade, R
,
Mitchell, C
,
Hancock, J
,
Hough, R
,
Rowntree, C
,
Richards, S
Format:
Journal article
Izdano:
2013
Zaloga
Opis
Other Versions (1)
Podobne knjige/članki
Knjižničarski pogled
Opis
Izvleček:
Podobne knjige/članki
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
od: Vora, A, et al.
Izdano: (2013)
UKALL 2003, A Randomised Trial Investigating Treatment Intensification for Children and Young Adults with Minimal Residual Disease Defined High Risk Acute Lymphoblastic Leukaema
od: Vora, A, et al.
Izdano: (2012)
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
od: Vora, A, et al.
Izdano: (2014)
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
od: Vora, A, et al.
Izdano: (2014)
UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
od: Vora, A, et al.
Izdano: (2010)